Duheng Biotechnology Co, .Ltd

Company Description

Having established itself as a major Manufacturer and Exporter of Flunixin Meglumine,Cyproterone Acetate,6a-Methylprednisolone,Budesonide,Capecitabine and so on around the world, Duheng Biotechnology Co, .Ltd had been earning US$5 Million - US$10 Million annually since its inception 6 Years ago. With an export rate of about US$5 Million - US$10 Million earned yearly, the estimated market share of Duheng Biotechnology Co, .Ltd is Australia,Canada,Germany,France,United Kingdom. Having said all of this, European and Oceanic market is still yet to be discovered by the industry; however, this graph may change ahead in the future. Originating from Shanghai, Shanghai, China, Duheng Biotechnology Co, .Ltd started off with an initial investment of US$1 Million in 2014. A Private Limited with Have Own Export License; the company plans to expand its roots in different countries in the coming years. For any further details on Glibenclamide products, feel free to contact Liu on provided details.